Wuxi, China

Haiqin Chen

USPTO Granted Patents = 7 

Average Co-Inventor Count = 7.4

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Jiangsu, CN (2015)
  • Wuxi, CN (2016 - 2024)

Company Filing History:


Years Active: 2015-2024

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations of Haiqin Chen in Microbial Engineering

Introduction

Haiqin Chen is a prominent inventor based in Wuxi, China. She has made significant contributions to the fields of protein engineering and microbial engineering. With a total of 7 patents to her name, her work focuses on the production of valuable compounds through innovative methods.

Latest Patents

Haiqin Chen's latest patents include groundbreaking inventions such as linoleic acid isomerase and its application in the production of conjugated linoleic acid. This invention discloses linoleic acid isomerases that are utilized to produce conjugated linoleic acid, achieving a conversion rate ranging from 12.1% to 42.1%. The method ensures that the percentage of cis9, trans11-CLA in the final product can reach between 84.3% and 89.1%. Another notable patent is related to diacylglycerol acyltransferase 1, which catalyzes the synthesis of triacylglycerol. This invention enhances the ability of microorganisms to produce polyunsaturated fatty acids (PUFAs) through genetic engineering, significantly increasing the content of total fatty acids and triacylglycerol.

Career Highlights

Haiqin Chen is affiliated with Jiangnan University, where she continues to advance her research and innovations. Her work has garnered attention for its practical applications in the food and biotechnology industries.

Collaborations

She collaborates with notable colleagues such as Hao Zhang and Yongquan Chen, contributing to a dynamic research environment that fosters innovation.

Conclusion

Haiqin Chen's contributions to microbial engineering and protein engineering are paving the way for new advancements in the production of essential fatty acids. Her innovative patents reflect her commitment to enhancing safety and yield in biotechnological applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…